Janneke W de Boer

10PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 15, 2026
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registry.

|Feb 10, 2026
Author Correction: Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Janneke W de Boer, Kylie Keijzer, Jaap A van Doesum

|Nov 25, 2025
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Janneke W de Boer, Kylie Keijzer, Jaap A van Doesum

|Jul 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL.

Janneke W de Boer, Kylie Keijzer, Suzanne van Dorp

|Apr 01, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy.

Gloria Iacoboni, Kai Rejeski, Víctor Navarro

|Mar 06, 2024
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.

Kylie Keijzer, Janneke W de Boer, Jaap A van Doesum

Pageof 2

Frequent Collaborators

9 joint publications

Tom van Meerten

6 joint publications

Kylie Keijzer

5 joint publications

Joost Sp Vermaat

4 joint publications

Margot Jak